PANITUMUMAB

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
22071
Randomized Phase III trial on postoperative chemoradiation in combination with anti EGFR-antibody versus postoperative chemoradiation in head and neck squamous cell carcinomas (HNSCC) with high risk of locoregional recurrence

Back to Protocol section